NET PROFIT (x1000 SEK)
Novo Nordisk Region Europe A/S
Closing information (x1000 SEK)
| Closing information | 2023/12 | 2022/12 | 2021/12 |
| Turnover |
0
|
0
|
0 |
| Earnings before taxes |
360,496
|
0
|
309,552 |
| Total assets |
13,716,585
|
0
|
4,910,891 |
| Current assets |
1,189,514
|
0
|
377,149 |
| Current liabilities |
623,047
|
0
|
546,655 |
| Equity capital |
11,619,267
|
0
|
3,407,896 |
| - share capital |
161,345
|
0
|
149,039 |
| Employees (average) |
0
|
0
|
0 |
Financial ratios
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Solvency | 84.7% | 69.4% | |
| Turnover per employee | |||
| Profit as a percentage of turnover | |||
| Return on assets (ROA) | |||
| Current ratio | 190.9% | 69.0% | |
| Return on equity (ROE) | 3.1% | 9.1% | |
| Change turnover |
0
|
0
|
0 |
| Change turnover % | |||
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
Total value of public sale
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.